Cited by 342Functional Brain Connectivity StudiesTreatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive- behavioral therapy or antidepressant medication for major depressive disorder

Open access

Abstract

OBJECTIVE: The purpose of this article was to inform the first-line treatment choice between cognitive-behavioral therapy (CBT) or an antidepressant medication for treatment-naive adults with major depressive disorder by defining a neuroimaging biomarker that differentially identifies the outcomes of remission and treatment failure to these interventions. METHOD: Functional MRI resting-state functional connectivity analyses using a bilateral subcallosal cingulate cortex (SCC) seed was applied to 122 patients from the Prediction of Remission to Individual and Combined Treatments (PReDICT) study who completed 12 weeks of randomized treatment with CBT or antidepressant medication. Of the 122 participants, 58 achieved remission (Hamilton Depression Rating Scale [HAM-D] score ≤7 at weeks 10 and 12), and 24 had treatment failure (<30% decrease from baseline in HAM-D score). A 2×2 analysis of variance using voxel-wise subsampling permutation tests compared the interaction of treatment and outcome. Receiver operating characteristic curves constructed using brain connectivity measures were used to determine possible classification rates for differential treatment outcomes. RESULTS: The resting-state functional connectivity of the following three regions with the SCC was differentially associated with outcomes of remission and treatment failure to CBT and antidepressant medication and survived application of the subsample permutation tests: the left anterior ventrolateral prefrontal cortex/insula, the dorsal midbrain, and the left ventromedial prefrontal cortex. Using the summed SCC functional connectivity scores for these three regions, overall classification rates of 72%-78% for remission and 75%-89% for treatment failure was demonstrated. Positive summed functional connectivity was associated with remission with CBT and treatment failure with medication, whereas negative summed functional connectivity scores were associated with remission to medication and treatment failure with CBT. CONCLUSIONS: Imaging-based depression subtypes defined using resting-state functional connectivity differentially identified an individual's probability of remission or treatment failure with first-line treatment options for major depression. This biomarker should be explored in future research through prospective testing and as a component of multivariate treatment prediction models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2016.16050518

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 9

  1. Cuijpers P, Depress Anxiety
  2. Samson AC, 2011, J Psychiatr Res, 45, 1214
  3. Little JT, 1996, Psychopharmacol Bull, 32, 629
  4. Konarski JZ, 2009, J Psychiatry Neurosci, 34, 175
  5. First MB, 1995, Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0)
  6. Owens MJ, Dunlop BW, Plott S, et al: Poster presentation: Estimates of serotonin or norepinephrine transporter occupancy do not predict efficacy in a 12 week trial. Presented at the proceedings of the 54th Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Fla, 2015
  7. 10.1016/j.jpsychires.2010.09.007 · DOI · Paper page
  8. 10.1016/j.biopsych.2008.04.033 · DOI · Paper page
  9. 10.1016/j.pscychresns.2008.09.004 · DOI

Cited by

Sorted by citations

Items 301–342 of 342

Metadata

Authors
Dunlop, B. W., Rajendra, J. K., Craighead, W. E., Kelley, M. E., McGrath, C. L., Choi, K. S., Kinkead, B., Nemeroff, C. B., & Mayberg, H. S.
Affiliations
Harvard University (US)
Venue
American Journal of Psychiatry
Published
2017-06-01
Volume
174
Issue
6
Pages
533-545
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2600118519
Cited by
342
References
80
Citations by year
2026: 20 · 2025: 32 · 2024: 30 · 2023: 30 · 2022: 31 · 2021: 47 · 2020: 55 · 2019: 50 · 2018: 28 · 2017: 19
FWCI
23.85
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01mh080880-05, UL1TR000454)
  • National Institute of Mental Health (K23MH086690, R01-MH080880, P50MH077083)
  • National Center for Research Resources (UL1RR025008, M01RR000039)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, resting-state functional connectivity, cognitive behavioral therapy, antidepressants, treatment response prediction, remission, treatment failure, neuroimaging biomarkers, ventromedial prefrontal cortex, dorsal midbrain, anterior insula, ventrolateral prefrontal cortex, individualized treatment selection
MeSH terms
Duloxetine Hydrochloride, Adolescent, Adult, Aged, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Dominance, Cerebral, Female, Gyrus Cinguli, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Nerve Net, Psychiatric Status Rating Scales, Citalopram, Cognitive Behavioral Therapy, Outcome Assessment, Health Care, Prefrontal Cortex, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review